{"id":2015,"date":"2026-03-12T11:01:00","date_gmt":"2026-03-12T11:01:00","guid":{"rendered":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/?page_id=2015"},"modified":"2026-03-12T11:42:02","modified_gmt":"2026-03-12T11:42:02","slug":"fast-study","status":"publish","type":"page","link":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/fast-study\/","title":{"rendered":"FAST"},"content":{"rendered":"\n
<\/div>
<\/div><\/div>
\n

Feasibility and Acceptability of Scalable Tests Brain study<\/h1>\n\n\n\n

FAST: Feasibility study and acceptability study of scalable biomarkers of brain health<\/h3>\n<\/div><\/div><\/div><\/div><\/div>\n\n\n\n
\n
\"DFP<\/figure>
\n

Project Details<\/strong><\/p>\n\n\n\n

Start Date
February 2026<\/strong><\/p>\n\n\n\n

Status
Open to Recruitment<\/strong><\/p>\n\n\n\n

Principal Investigator
Jessica Crossan<\/a><\/p>\n\n\n\n

NDN Study Lead
Marian Montanha<\/a><\/p>\n\n\n\n

Main Research Site
Western General Hospital<\/strong><\/p>\n<\/div><\/div>\n\n\n\n

This research study is trying to better understand a person\u2019s risk for developing Alzheimer\u2019s Disease<\/strong>, using digital cognitive assessments and blood tests.<\/p>\n\n\n\n

What Happens In This Study?<\/strong><\/p>\n\n\n\n

You will take part in a blood test and some online cognitive assessments.<\/p>\n\n\n\n

Can I Join This Study?<\/strong><\/p>\n\n\n\n

To take part in this medical trial, you must meet these 4 requirements<\/strong>:<\/p>\n\n\n\n

    \n
  1. Your Diagnosis:<\/strong> You can take part if you are cognitively healthy OR have been diagnosed with dementia or Mild Cognitive Impairment<\/strong> by your GP or at a memory clinic.<\/li>\n\n\n\n
  2. Your Age:<\/strong> You are 50 years old, or older<\/strong>.<\/li>\n\n\n\n
  3. Your Permission:<\/strong> You must be able to understand what happens in the study and sign a form (called informed consent<\/strong>) to say you agree to join.<\/li>\n\n\n\n
  4. Your Time:<\/strong> You must do your best to attend all your study visits, and follow the rules of the study until it ends.<\/li>\n<\/ol>\n\n\n\n

    Study Length<\/strong>: 52 weeks<\/p>\n\n\n\n

    Number of appointments<\/strong>: 3 visits<\/p>\n\n\n\n

    More information on the trial can be found on the FAST website.<\/a><\/p>\n<\/div><\/div>\n\n\n\n